QTTB Q32 Bio Inc Net earnings per share growth forecast for next year
The estimated annual EPS growth for the next period demonstrates the potential of Q32 Bio Inc. (QTTB), which develops dual-action drugs for inflammation suppression. The company is currently focusing on R&D and targeted immune regulation therapy, while the value of -51.80 represents the current metric. A strategic alliance with global pharma behemoths minimizes development costs, ensuring stable growth in margins and free cash flow.
Comprehensive metric breakdowns and analytics for Q32 Bio (QTTB)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
- earnings and valuation multiples information:
QTTB - Company Net Income|Future Profit Q32 Bio Inc.|QTTB - Company Value to Net Income|Forward P/E Multiple Q32 Bio Inc|QTTB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Q32 Bio|QTTB - Operating profit before amortization|Net earnings per share (EPS TTM) Q32 Bio|QTTB - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months q32bio.com|QTTB - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Q32 Bio Inc.
- total revenue and sales volume data:
Fundamental company valuation:Q32 Bio Inc., QTTB
The use of a network of independent CRO contractors for immunological tests at Q32 Bio Inc. (QTTB) directly impacts the company's EPS projections for the coming year. This indicator measures the consolidated forecast for earnings per share, reflecting analysts' weighted average confidence in the scalability of the business model. The trend is established by comparing current market expectations with historical data, allowing investors to assess the asset's fundamental resilience to external risks.
Key competitors
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|KNSA - Net earnings per share growth forecast for next year|Net earnings per one share growth forecast for next year Grifols Biemat (GRFS)|ADPT (Adaptive Biotechnologies) - Expected earnings per share growth for next year|CLDX (celldex.com) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year AUPH|BCRX: Expected earnings per share trend next year|Earnings growth forecast for next year VERA|Net earnings per share growth forecast for next year DNTH (Dianthus Corp)|Earnings growth forecast for next year PHVS (Pharvaris N.V.)|Consensus forecast of earnings per share growth for next year abcellera.com (ABCL)|TRML - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Precigen Inc|PHAR (Pharming) - Expected earnings per share growth for next year|Nektar Corp - Expected earnings per share trend next year|UPB (Upstream Bio Inc) - Earnings growth forecast for next year|zenasbio.com (ZBIO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Immunome (IMNM)|Gossamer Bio Inc - Projected earnings per share growth rate for next year|Earnings growth forecast for next year KALV (KalVista Pharmaceuticals Inc)|SEPN - Expected earnings per share growth for next year|PVLA: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year savarapharma.com SVRA|Rigel Pharmaceuticals, Inc. (RIGL) - Net earnings per share growth forecast for next year|Net earnings per one share growth forecast for next year AnaptysBio Inc ANAB|Expected earnings per share growth for next year ATXS|ENGN (enGene Corp) - Projected earnings per share increase next year|Expected earnings per share growth for next year RAPT (RAPT Therapeutics, Inc.)|Projected earnings per share increase next year JBIO|Earnings growth forecast for next year ACRS (Aclaris Therapeutics, Inc.)|Kyverna Therapeutics Inc. - Net earnings per share growth forecast for next year|TLSA - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year CABA|VTYX: Earnings growth forecast for next year|theratech.com - Expected earnings per share trend next year|AVTX (Avalo Therapeutics) - Earnings growth forecast for next year|Earnings growth forecast for next year Eledon Pharmaceuticals Inc.|Net earnings per share growth forecast for next year Agenus Inc (AGEN)|CLYM (Climb Bio, Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Zura Bio Limited ZURA|ATYR - Expected earnings per share growth for next year|Adagene Corp - Earnings growth forecast for next year|IMA - Earnings growth forecast for next year|STTK (shattucklabs.com) - Expected earnings per share growth for next year|Equillium - Expected earnings per share trend next year|CNTB (Connect Biopharma Holdings) - Earnings growth forecast for next year|Immunic Inc (IMUX) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Atara Biotherapeutics (ATRA)|Expected earnings per share growth for next year inflarx.de IFRX|Net earnings per share growth forecast for next year X4 Pharma XFOR|ACET - Expected earnings per share growth for next year|CELU: Expected earnings per share growth for next year|INMB - Earnings growth forecast for next year|Barinthus Biotherapeutics plc (BRNS) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year KZR|SABS (SAB Biotherapeutics, Inc) - Earnings growth forecast for next year|Expected net earnings per share growth next year Akari Therapeutics, Plc AKTX|Net earnings per share growth forecast for next year Enlivex Therapeutics (ENLV)|geovax.com (GOVX) - Net earnings per one share growth forecast for next year|Edesa Biotech - Expected earnings per share growth for next year|iBio Inc - Net earnings per share growth forecast for next year|CARM: Expected earnings per share growth for next year|Expected earnings per share trend next year XTLB (XTL Bio)|BOLT: Earnings growth forecast for next year|HCWB (HCW Biologics) - Net earnings per share growth forecast for next year|APVO (Aptevo Therapeutics, Inc.) - Earnings growth forecast for next year|AIM ImmunoTech, Inc. (AIM) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Aditxt (ADTX)|GRI - Expected net earnings per share growth next year|XORTX Therapeutics Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year HIND|Revelation Biosciences, Inc. - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Indaptus Therapeutics Inc INDP|Scinai (SCNI) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year CALI|AFMD (Affimed NV) - Earnings growth forecast for next year|Expected earnings per share growth for next year Allakos Therapeutics (ALLK)|Expected earnings per share growth for next year HOOK (HOOKIPA Pharma Inc.)|Consensus forecast of earnings per share growth for next year igmbio.com|Net earnings per share growth forecast for next year iTeos ITOS|Net earnings per one share growth forecast for next year Ocean Biomedical Corp|TCBP: Expected earnings per share growth for next year|thirdharmonicbio.com - Projected earnings per share increase next year
